Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Danian Ye | M | 85 |
Chinese Academy of Sciences
| 33 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James Sulat | M | 73 |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 10 years |
| Jie Feng | F | 38 | 11 years | |
| Elliot Goldstein | M | 73 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 6 years |
| Nick Fazzie | M | - |
University of Delaware
| 6 years |
| Jing Wu | M | - |
University of Delaware
| 5 years |
| Ling Wang | M | 67 |
Chinese Academy of Sciences
| 3 years |
| Zhi Gang Zhao | M | 64 | 5 years | |
| Li Ming Fan | F | 66 |
Shandong University
| 7 years |
| Suzanne M. Hay | F | 52 |
University of Delaware
| 5 years |
| Sheng Ping Zhang | M | 59 |
Shandong University
| 13 years |
| Ye Hong Zhang | M | 60 | 2 years | |
| De Gui Tan | M | 59 |
Shandong University
| 6 years |
| John M. Borkholder | M | 55 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 8 years |
| Yiping Tan | M | - |
Chinese Academy of Sciences
| 5 years |
| Xin Li Zhao | M | 58 |
Chinese Academy of Sciences
| 11 years |
| Siu Kwan Sik | M | 56 | - | |
| Ernest Mario | M | 85 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 12 years |
| Michael S. Rabson | M | 70 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 9 years |
| Russell Howard | M | 74 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 11 years |
| Louis Lange | M | 72 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 8 years |
| Brian Tande | M | - |
University of Delaware
| 4 years |
| Jason Jankosky | M | - |
University of Delaware
| 4 years |
| Christian Kniescheck | M | 52 |
University of Delaware
| 2 years |
| Russell Shaller | M | 60 |
University of Delaware
| 2 years |
| Kate Miller | F | - |
University of Delaware
| 4 years |
| Yun Wei Zhang | M | 59 |
Shandong University
| 4 years |
| Hua Ma | M | 47 |
Shandong University
| 4 years |
| Tim Wang | M | - |
Shandong University
| 4 years |
| Þórður Pálsson | M | 56 |
University of Delaware
| 2 years |
| Paul Laurence Miller | M | 48 |
University of Delaware
| 4 years |
| Zunaid Kazi | M | - |
University of Delaware
| 3 years |
| Brendan Furey | M | - |
University of Delaware
| 4 years |
| Dennis Michael DeBusschere | M | - |
University of Delaware
| 4 years |
| Edvaldo Guimaraes | M | - |
University of Delaware
| 2 years |
| Bill Bellinzoni | M | 48 |
University of Delaware
| 4 years |
| George Major | M | - |
University of Delaware
| 4 years |
| Ken Nuttall | M | - |
University of Delaware
| 4 years |
| Yao Hua Wu | M | 61 |
Shandong University
| 3 years |
| Xue Xu Gao | M | 55 |
Shandong University
| 4 years |
| Gila Weiss | F | - |
University of Delaware
| 5 years |
| Zhi Xun Wei | M | 55 |
Shandong University
| 4 years |
| Li Cheng Liu | M | 56 |
Shandong University
| 4 years |
| Song Gao | M | 54 |
Shandong University
| 4 years |
| Christopher Stanczuk | M | - |
University of Delaware
| 3 years |
| Qing Jun Wu | M | 59 |
Shandong University
| 4 years |
| Seth Brodsky | M | - |
University of Delaware
| 4 years |
| Christopher Smith | M | - |
University of Delaware
| 3 years |
| Matthew W. Lakofsky | M | - |
University of Delaware
| 4 years |
| Lubin Wang | M | 68 |
Shandong University
| 1 years |
| Glenn Alan Turano | M | - |
University of Delaware
| 4 years |
| Guo hua Zhang | M | 55 |
Shandong University
| 4 years |
| Boris Sovic | M | 67 |
University of Delaware
| 4 years |
| Bing Zhi | M | 57 |
Shandong University
| 4 years |
| Yimin Huang | M | - |
University of Delaware
| 2 years |
| Joe Finer | M | - |
University of Delaware
| 4 years |
| Zhi Sheng Chen | M | 52 |
University of Delaware
| 3 years |
| J. Diskin | M | - |
University of Delaware
| 4 years |
| Frederick J. Goetz | M | 48 |
University of Delaware
| 4 years |
| Matthew J. Riley | M | - |
University of Delaware
| 4 years |
| Wei Xing Wang | M | 60 |
Shandong University
| 4 years |
| Paul A. Randazzo | M | - |
University of Delaware
| 4 years |
| Brian M. Baynes | M | - |
University of Delaware
| 4 years |
| Kevin Doherty | M | - |
University of Delaware
| 4 years |
| Marnie Merriam | F | - |
University of Delaware
| 4 years |
| Jake Weaver | M | - |
University of Delaware
| 4 years |
| Greg Feig | M | - |
University of Delaware
| 4 years |
| Michael Seidl | M | - |
University of Delaware
| 3 years |
| Walter Zhao | M | 60 |
Shandong University
| 4 years |
| Lindsey Houghton | M | - |
University of Delaware
| 4 years |
| Gary R. Mottola | M | - |
University of Delaware
| 5 years |
| Bradley Pennington Pike | M | - |
University of Delaware
| 5 years |
| Michael Charles Wissel | M | 49 |
University of Delaware
| 4 years |
| Gene Neavin | M | - |
University of Delaware
| 4 years |
| John G. Curd | M | 78 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | - |
| Ying Yan | F | 58 |
Shandong University
| 4 years |
| Yiling Zeng | M | 64 |
Shandong University
| 4 years |
| Bryan Paul Katz | M | - |
University of Delaware
| 4 years |
| Matthew Garth | M | 50 |
University of Delaware
| 4 years |
| Joshua Pruss | M | - |
University of Delaware
| 4 years |
| Michael Andrew Lonia | M | - |
University of Delaware
| 5 years |
| An Xiang Chen | M | 61 |
Shandong University
| 4 years |
| Jiang Yu | M | 52 |
Shandong University
| 4 years |
| Cathryn Clary | M | - |
University of Delaware
| 2 years |
| Brian McHugh | M | - |
University of Delaware
| 4 years |
| Nicole Zalkin | F | - |
University of Delaware
| 4 years |
| Derek A. Zundl | M | - |
University of Delaware
| 4 years |
| Matthew Werner | M | - |
University of Delaware
| 4 years |
| Keith Langan | M | - |
University of Delaware
| 5 years |
| Justin Arthur Venneri | M | - |
University of Delaware
| 4 years |
| Shu Chen Hao | M | 60 |
Shandong University
| 4 years |
| Bob White | M | - |
University of Delaware
| 4 years |
| David G. Landskowsky | M | 45 |
University of Delaware
| 4 years |
| Yu Min Sui | M | 60 |
Shandong University
| 4 years |
| Larry Wang | M | - |
Shandong University
| 4 years |
| Raisa D. Gusakova-Rivero | F | - |
University of Delaware
| 4 years |
| Yingyuan Wang | F | - |
Shandong University
| 4 years |
| William M. Lynch | M | - |
University of Delaware
| 4 years |
| Fuchang Wang | M | 64 |
Shandong University
| 4 years |
| Ravi Dattani | M | - |
University of Delaware
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 66 | 66.00% |
| China | 34 | 34.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sean X. Du
- Personal Network
